0001062993-12-004075.txt : 20121012 0001062993-12-004075.hdr.sgml : 20121012 20121012141411 ACCESSION NUMBER: 0001062993-12-004075 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20121012 DATE AS OF CHANGE: 20121012 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: IntelGenx Technologies Corp. CENTRAL INDEX KEY: 0001098880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870638336 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-82768 FILM NUMBER: 121141686 BUSINESS ADDRESS: STREET 1: 6425 ABRAMS CITY: VILLE SAINT LAURENT STATE: A8 ZIP: H4S 1X9 BUSINESS PHONE: 514-331-7440 MAIL ADDRESS: STREET 1: 6425 ABRAMS CITY: VILLE SAINT LAURENT STATE: A8 ZIP: H4S 1X9 FORMER COMPANY: FORMER CONFORMED NAME: BIG FLASH CORP DATE OF NAME CHANGE: 19991112 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BluMont Capital Corp CENTRAL INDEX KEY: 0001516366 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 70 UNIVERSITY AVENUE STREET 2: SUITE 1200 CITY: TORONTO STATE: A6 ZIP: M5J 2M4 BUSINESS PHONE: (416)216-3566 MAIL ADDRESS: STREET 1: 70 UNIVERSITY AVENUE STREET 2: SUITE 1200 CITY: TORONTO STATE: A6 ZIP: M5J 2M4 SC 13G 1 sc13g.htm SCHEDULE 13G BluMont Capital Corporation: Schedule 13-G - Filed by newsfilecorp.com

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. _______)*

IntelGenx Technologies Corp.
(Name of Issuer)

COMMON STOCK
(Title of Class of Securities)

45822R101
(CUSIP Number)

October 10, 2012
(Date of Event Which Requires Filing of This Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

  [  ] Rule 13d-1(b)
  [X] Rule 13d-1(c)
  [  ] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Page 1 of 6 pages



CUSIP No. 45822R101

1.

NAMES OF REPORTING PERSONS  BluMont Capital Corporation
I.R.S. Identification Nos. of above persons (entities only).    N/A

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

 

 

(a) [    ]

(b) [    ]

 

3.

SEC USE ONLY


 

4.

CITIZENSHIP OR PLACE OF ORGANIZATION

Ontario


NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5.

SOLE VOTING POWER
6,397,645 (1)


6.

SHARED VOTING POWER
0


7.

SOLE DISPOSITIVE POWER
6,397,645 (1)

 

8.

SHARED DISPOSITIVE POWER
0


9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

6,397,645 (1)


10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) 
[   ] 

 

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

12.89% (2)


12.

TYPE OF REPORTING PERSON (See Instructions)

CO


(1) This amount includes 6,142,645 shares of common stock and unexercised warrants to purchase (i) 225,000 shares at a price of $0.50 per share; and (ii) 30,000 shares at a price of $0.74 per share.

(2) Based upon 49,623,259 issued and outstanding shares of common stock reported by the Issuer in its Quarterly Report on Form 10-Q for the period ended June 30, 2012.

Page 2 of 6 pages


Item 1.

(a)

Name of Issuer

IntelGenx Technologies Corp.

(b)

Address of Issuer’s Principal Executive Offices

6425 Abrams, Ville St. Laurent, Quebec, Canada H4S 1X9

Item 2.

(a)

Name of Person Filing

BluMont Capital Corporation
70 University Avenue
Suite 1200
Toronto, Ontario Canada
M5J 2M4

(b)

Address of Principal Business Office or, if none, Residence

See Item 2(a)

(c)

Citizenship or Place of Organization

Ontario

(d)

Title of Class of Securities

Common Stock

(e)

CUSIP Number

45822R101

Item 3. If the statement is filed pursuant to §§ 240.13d -1(b) or 240.13d -2(b) or (c), check whether the person filing is a:

(a) [  ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78c);
     
(b) [  ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     
(c) [  ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     
(d) [  ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
     
(e) [  ] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
     
(f) [  ] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
     
(g) [  ] A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
     
(h) [  ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
(i) [  ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
(j) [  ]

Group, in accordance with § 240.13d-1(b)(1)(ii)(J).

Page 3 of 6 pages



Item 4. Ownership.
 
1.

BluMont Capital Corporation

     
(a)

Amount beneficially owned: 6,397,645. This amount includes 6,142,645 shares of common stock and unexercised warrants to purchase (i) 225,000 shares at a price of $0.50 per share; and (ii) 30,000 shares at a price of $0.74 per share.

     
(b)

Percent of class: 12.89% . Based upon 49,623,259 issued and outstanding shares of common stock reported by the Issuer in its Quarterly Report on Form 10-Q for the period ended June 30, 2012.

     
(c)

Number of shares as to which the person has:


  (i) Sole power to vote or to direct the vote 6,397,645.
     
  (ii) Shared power to vote or to direct the vote 0.
      
  (iii) Sole power to dispose or to direct the disposition of 6,397,645.
     
  (iv) Shared power to dispose or to direct the disposition of 0.

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. [ ]

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

Item 8. Identification and Classification of Members of the Group.

Not applicable.

Item 9. Notice of Dissolution of Group.

Not applicable

Item 10. Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Page 4 of 6 pages


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

  October 12, 2012
  Date
  BluMont Capital Corporation
   
             By: /s/ Stephen Johnson
             Name/Title: Stephen Johnson, Chief Financial Officer

The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d -7 for other parties for whom copies are to be sent.

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

Page 5 of 6 pages


EXHIBIT 1

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Dated: October 12, 2012

BluMont Capital Corporation

             By: /s/ Stephen Johnson
             Name/Title: Stephen Johnson, Chief Financial Officer

Page 6 of 6 pages